Number of women available in the analysis and number of measurements in the study
| . | England . | Denmark . | Total . |
|---|---|---|---|
| Number of women in analysis | |||
| Eligible | 61 | 71 | 132 |
| Excluded | 12 | 3 | 15 |
| Included | 49 | 68 | 117 |
| Type 1 diabetes | 35 | 54 | 89 |
| Type 2 diabetes | 14 | 14 | 28 |
| Trimester 1 | 31 | 64 | 95 |
| Trimester 2 | 44 | 52 | 96 |
| Trimester 3 | 30 | 50 | 80 |
| LGA infant | 23/49 (46.9%) | 31/68 (45.6%) | 54/117 (46.1%) |
| Number of measurements | 256,640 | 1,423,706 | 1,680,346 |
| Number of measurement episodes | 171 | 588 | 759 |
| . | England . | Denmark . | Total . |
|---|---|---|---|
| Number of women in analysis | |||
| Eligible | 61 | 71 | 132 |
| Excluded | 12 | 3 | 15 |
| Included | 49 | 68 | 117 |
| Type 1 diabetes | 35 | 54 | 89 |
| Type 2 diabetes | 14 | 14 | 28 |
| Trimester 1 | 31 | 64 | 95 |
| Trimester 2 | 44 | 52 | 96 |
| Trimester 3 | 30 | 50 | 80 |
| LGA infant | 23/49 (46.9%) | 31/68 (45.6%) | 54/117 (46.1%) |
| Number of measurements | 256,640 | 1,423,706 | 1,680,346 |
| Number of measurement episodes | 171 | 588 | 759 |